Mecobalamin

Bibliography

• Guest JR, Friedman S, Wood DD, et al. A methyl analogue of cobamide coenzyme in relation to methionine synthesis by bacteria. Nature 1962;195:340-2
   PubMed Web of Science ®Google Scholar
• Barker HA, Weissbach H, Smyth RD. A coenzyme containing pseudovitamin B(12). Proc Natl Acad Sci USA 1958;44:1093-7
   PubMed Web of Science ®Google Scholar
• Banerjee R, Ragsdale SW. The many faces of vitamin B12: catalysis by cobalamin-dependent enzymes. Ann Rev Biochem 2003;72:209-47
   PubMed Web of Science ®Google Scholar
• Barker H. Corrinoid-dependent enzymic reactions. Ann Rev Biochem 1972;41:55-90
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SHD. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 2002;112:556-65
   PubMed Web of Science ®Google Scholar
• Austin RC, Lentz S, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004;11:S56-64
   PubMed Web of Science ®Google Scholar
• Kerkeni M, Addad F, Chauffert, et al. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 2006;39:821-5
   PubMed Web of Science ®Google Scholar
• Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57
   PubMed Web of Science ®Google Scholar
• Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62
   PubMed Web of Science ®Google Scholar
• Nygård O, Norderhuag JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6
   PubMed Web of Science ®Google Scholar
• Selhub J, Jacques PF, Bostom AG, et al. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham study population. J Nutr 1996;126:1258S-1265S
   PubMed Web of Science ®Google Scholar
• Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, espectially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-8
   PubMed Web of Science ®Google Scholar
• El-Khairy L, Ueland PM, Refsum H, et al. Plasma total cysteine as a risk factor for vascular disease: the european concerted action project. Circulation 2001;103:2544-9
   PubMed Web of Science ®Google Scholar
• Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006;333:1114-7
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-6
   PubMed Web of Science ®Google Scholar
• Herrmann W, Herrmann M, Joseph J, Tyagi SC. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clin Chem Lab Med 2007;45:1633-44
   PubMed Web of Science ®Google Scholar
• Herrmann M, Schmidt JP, Umanskaya N, et al. The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review. Clin Chem Lab Med 2007;45:1621-32
   PubMed Web of Science ®Google Scholar
• Obeid R, McCaddon A, Herrmann W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 2007;45:1590-606
   PubMed Web of Science ®Google Scholar
• Jamaluddin MS, Chen I, Yang F. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 2007;110: 3648-55
   PubMed Web of Science ®Google Scholar
• Berwanger CS, Jeremy JY, Stansby G. Homocysteine and vascular disease. Br J Surg 1995;82:726-31
   PubMed Web of Science ®Google Scholar
• Verhoef P, Kok FJ, Kruyssen DA, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc 1997;17:989-95
   PubMed Web of Science ®Google Scholar
• Yazaki Y, Chow G, Mattie M. A single-center, double-blinded, randomized controlled study to evaluate the relative efficacy of sublingual and oral vitamin B-complex administration in reducing total serum homocysteine levels. J Altern Complem Med 2006;12:881-5
   PubMed Web of Science ®Google Scholar
• Measurement and use of total plasma homocysteine. American Society of Human Genetics/American College of Medical Genetics Test and Transfer Committee Working Group. Am J Hum Genet 1998;63:1541-3
   PubMed Web of Science ®Google Scholar
• Ma X, Shen F, Liu A, et al. Clinidine, moxonidine, folic acid, and mecbalamin improve baroreflex function in stroke-prone, spontaneously hypertensive rats. Acta Pharmacol Sin 2007;28:1550-8
   PubMed Web of Science ®Google Scholar
• Andrès E, Loukili N, Noel E, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004;171:251-9
   PubMed Web of Science ®Google Scholar
• Head KA. Peripheral Neuropathy. Altern Med Rev 2006;11:294-329
   PubMed Web of Science ®Google Scholar
• Weir DG, Scott JM. The biochemical basis of the neuropathy in cobalamin deficiency. Baillieres Clin Haematol 1995;8:479-97
   PubMed Web of Science ®Google Scholar
• Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007;45:1694-9
   PubMed Web of Science ®Google Scholar
• Scalabrino G, Buccellato F, Veber D, et al. New basis of the neurotrophic action of vitamin B12. Clin Chem Lab Med 2003;41:1435-7
   PubMed Web of Science ®Google Scholar
• Liu KW, Dai LK, Jean W. Metformin-related vitamin B12 deficiency. Age Ageing 2006;35:200-1
   PubMed Web of Science ®Google Scholar
• Ting RZ, Szeto CC, Chan MH, et al. Risk factors of vitamin B12 deficiency in patients receiving metformin. Arch Intern Med 2006;166:1975-9
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Ejiri K, Baba S. Improvement of autonomic neuropathy after mecobalamin treatment in uremic patients on hemodialysis. Clin Ther 1987;9:607-14
   PubMed Web of Science ®Google Scholar
• Koyama K, Yoshida A, Takeda A, et al. Abnormal cyanide metabolism in uraemic patients. Nephrol Dial Transplant 1997;12:1622-8
   PubMed Web of Science ®Google Scholar
• Kikuchi M, Kashii S, Honda Y, et al. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest. Ophthalmol Vis Sci 1997;38:848-54
   PubMed Web of Science ®Google Scholar
• Methylcobalamin. Altern Med Rev 1998;3:461-3
   PubMedGoogle Scholar
• Obeid R, Morkbak AL, Munz W, et al. The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. Clin Chem 2006;52: 263-9
   PubMed Web of Science ®Google Scholar
• Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atheroclerosis 1993;103:149-57
   PubMed Web of Science ®Google Scholar
• Li Y, Ren L, Sun Z. Effects of mecobalamin on hyperhomocysteinemia in patients with type 2 diabetic nephropathy. Chin J New Drugs Clin Rem 2007;26:331-4
   Google Scholar
• Sato Y, Kaji M, Kondo I, et al. Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine. J Neurol Sci 2002;202:65-8
   PubMed Web of Science ®Google Scholar
• Gu W, Lu J, Yang G, et al. Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonase/paraoxonase activity in patients with type 2 diabetes mellitus. Natl Med J China 2007;87:256-8
   Google Scholar
• Sato Y, Honda Y, Iwamoto J, et al. Effect of folate and mecobalamin on hip fractures in patients with stroke. JAMA 2005;293:1082-8
   PubMed Web of Science ®Google Scholar
• Koyama K, Usami T, Takeuchi O, et al. Efficacy of methylcobalamin on lowering total homcysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 2002;17:916-22
   PubMed Web of Science ®Google Scholar
• Trimarchi H, Schiela, Freixas E, et al. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron 2002;91:58-63
   PubMed Web of Science ®Google Scholar
• Ide H, Fujiya S, Asanuma Y, et al. Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clin Ther 1987;9:183-92
   PubMed Web of Science ®Google Scholar
• Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg 1992;94:105-11
   PubMed Web of Science ®Google Scholar
• Beijing Methycobal Clinical Trial Collaborative Group. Effect of mecobalamin on diabetic neuropathies. Clin J Intern Med 1999;38:14-7
   Google Scholar
• Yoshioka K, Tanaka K. Effect of methylcobalamin on diabetic autonomic neuropathy as assessed by power spectral analysis of heart rate variations. Horm Metab Res 1995;27:43-4
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Nakazawa R, Azuma N, et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999;38:472-5
   PubMed Web of Science ®Google Scholar
• Sayo Y, Honda Y, Iwamoto J, et al. Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients. J Neurol Sci 2005;231:13-8
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhou Z. Clinical observation of combined therapeutic effect of prostaglandin E1 and mecobalamin on diabetic perpheral neuropathy. Bull Hunan Med Univ 2001;26:343-4
   Google Scholar
• Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan 2005;14:48-54
   PubMedGoogle Scholar
• Isoyama R, Kawai S, Shimizu Y, et al. Clinical experience with methylcobalamin (CH3-B12) for male infertility. Hinyokika Kiyo 1984;30:581-6
   Google Scholar
• Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 2001;18:185-92
   PubMed Web of Science ®Google Scholar
• Hoogeveen EK, Kostense P, Valk GD, et al. Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: the Hoorn Study. J Intern Med 1999;246:561-6
   PubMed Web of Science ®Google Scholar
• Bleie Ø, Semb AG, Grundt H, et al. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med 2007;262:244-53
   PubMed Web of Science ®Google Scholar
• The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77
   PubMed Web of Science ®Google Scholar
• Bønaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-88
   PubMed Web of Science ®Google Scholar
• Search Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors. Am Heart J 2007;154:815-23.e6
   PubMed Web of Science ®Google Scholar